Treatment-Resistant Depression (TRD)

Spravato Sparks Hope to Those Suffering from Treatment-Resistant Depression

Spravato Sparks Hope to Those Suffering from Treatment-Resistant Depression

Standard antidepressants, usually in conjunction with therapy, benefit many individuals diagnosed with severe depression. Unfortunately, for approximately 30% of these individuals, who have Treatment-Resistant Depression (TRD), these drugs have little or no effect. Treatment-resistant does not imply “no hope;” It’s simply a little more difficult. Innovative, cutting-edge therapies are constantly on the horizon, such as Spravato, a nasal spray that…

learn more

First Breakthrough Medicine for Patients with Treatment-Resistant Depression (TRD) in Decades

First Breakthrough Medicine for Patients with Treatment-Resistant Depression (TRD) in Decades

There is happy news for those suffering from severe Treatment-Resistant Depression (TRD): Spravato (Esketamine) is a revolutionary medication that can bring relief from depressive episodes within hours. For the very first time in 60 yrs, we have a unique antidepressant treatment. For some patients, Spravato treatment is groundbreaking, allowing them to live a life free of depression. What exactly is…

learn more